loader
Please Wait
Applying Filters...

Looking for Capsule Delayed Release Finished Formulations containing Red Ferric Oxide S? Find Red Ferric Oxide S based pharmaceutical excipients on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7BUDESONIDE

02 1CREON

03 3DIMETHYL FUMARATE

04 1ENTOCORT EC

05 7FENOFIBRIC ACID

06 1OMEPRAZOLE MAGNESIUM

07 1ORTIKOS

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

BUDESONIDE

Drug : BUDESONIDE

Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

Application Number : 206623

Country : US

Patented : No

Dr Reddy Company Banner

03

arrow
Luxepack
Not Confirmed

04

arrow
Luxepack
Not Confirmed

05

arrow
Luxepack
Not Confirmed

06

arrow
Luxepack
Not Confirmed
arrow
Luxepack
Not Confirmed

BUDESONIDE

Drug : BUDESONIDE

Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

Application Number : 206134

Country : US

Patented : No

blank

07

RISING PHARMA
arrow
Luxepack
Not Confirmed
RISING PHARMA
Country
arrow
Luxepack
Not Confirmed

CHOLINE FENOFIBRATE

Drug : FENOFIBRIC ACID

Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

Application Number : 211626

Country : US

Patented : No

blank

08

RISING PHARMA
arrow
Luxepack
Not Confirmed
RISING PHARMA
Country
arrow
Luxepack
Not Confirmed

BUDESONIDE

Drug : BUDESONIDE

Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

Application Number : 207367

Country : US

Patented : No

blank

09

ENDO OPERATIONS
arrow
Luxepack
Not Confirmed
ENDO OPERATIONS
Country
arrow
Luxepack
Not Confirmed

CHOLINE FENOFIBRATE

Drug : FENOFIBRIC ACID

Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

Application Number : 201573

Country : US

Patented : No

blank

10

NORVIUM BIOSCIENCE
arrow
Luxepack
Not Confirmed
NORVIUM BIOSCIENCE
Country
arrow
Luxepack
Not Confirmed

CHOLINE FENOFIBRATE

Drug : FENOFIBRIC ACID

Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

Application Number : 200913

Country : US

Patented : No

blank